XLV Stock Recent News

After impressive quarterly results on Wednesday, here are two highly-ranked Zacks Medical sector stocks that investors may want to consider.

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.

The Health Care Select Sector SPDR Fund is an ETF that tracks the performance of the U.S. health care sector. XLV has a diverse portfolio of holdings, including well-known companies like Eli Lilly, UnitedHealth Group, and Johnson & Johnson. The ETF's performance has been hurt by slowing demand for Covid-related treatments, but it has performed closely to similar healthcare ETFs.

UnitedHealth (UNH) reported better-than-expected third-quarter 2023 results. Earnings and revenues breezed past the Zacks Consensus Estimate.

Though the fourth quarter of a year normally doesn't see turbulent trading as it includes the all-important holiday season, Middle East tensions this year could cause a different fate for the markets.

Punit Mehta, Guggenheim Securities head of healthcare investment banking, joins 'Squawk on the Street' to discuss the healthcare M&A market, how Mehta sees the growth of the new class of weight-loss drugs affecting M&A, and much more.

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the Health Care Select Sector SPDR ETF (XLV), a passively managed exchange traded fund launched on 12/16/1998.

The "Halftime Report" traders give their top picks to watch for the second half.

Per Earnings Trends issued on Aug 23, 2023, 96% of the S&P 500 companies have reported so far with 79.4% earnings beat ratio and 65.4% revenue beat ratio.

I don't know about you, but this market stresses me out. Rising blood pressure is correlated to my posts on X, alongside rising risks of an imminent credit event.